查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1973784

锗-68/镓-68发生器市场：按技术、发生器容量、应用和最终用户划分－2026年至2032年全球预测

Germanium-68 Gallium-68 Generators Market by Technology, Generator Capacity, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，锗-68/镓-68 发生器市场价值将达到 445 亿美元，到 2026 年将成长至 510.6 亿美元，到 2032 年将达到 1,200.9 亿美元，复合年增长率为 15.23%。

主要市场统计数据
基准年 2025 445亿美元
预计年份：2026年 510.6亿美元
预测年份 2032 1200.9亿美元
复合年增长率 (%) 15.23%

简单介绍锗-68/镓-68发生器技术如何改变医疗保健环境中的分散式PET示踪剂供应和放射性药物工作流程。

由发生器产生的正电子发射同位素领域仍然是分子成像和放射性药物生产流程的核心。锗-68/镓-68发生器技术支援短寿命镓-68的去中心化供应链，使医院、诊断中心、研究机构和製药公司无需即时使用迴旋加速器即可利用PET示踪剂。随着心臟病学、神经病学和肿瘤学领域对标靶PET诊断的临床需求不断增长，发生器系统也不断改进以满足不同的使用者需求，法规结构也不断发展以保障病患安全和产品品质。

技术创新、将临床应用扩展到肿瘤学以外的领域以及供应链的韧性正在推动基于发生器的 PET 同位素生态系统发生重大结构性变化。

技术创新、监管成熟和临床模式的演变正在改变PET同位素发生器市场。自动化和整合系统结构降低了操作人员的差异性，并实现了多通道处理，从而满足了商业生产和医院放射性药物部门日益增长的需求。这些技术进步辅以更完善的品管和数位化可追溯性，提高了对区域和国际监管要求的合规性。

对 2025 年美国关税措施对整个发电机供应链的供应商重组、成本管理策略和采购趋势的影响进行分析研究。

2025年美国的关税环境为发电机系统及相关耗材的供应商和终端用户带来了新的营运和策略压力。对进口零件和成品发电机征收的关税措施改变了依赖全球化生产链的製造商的成本结构，促使他们重新评估筹资策略，并促使一些供应商考虑将生产外包或在美国国内组装，以减轻额外的进口关税影响。这些商业性因应措施对医院、诊断中心和商业放射性药物药局的采购计画、库存政策和资本投资决策产生了显着的连锁反应。

详细的細項分析揭示了应用、最终用户、技术类型和发电机容量如何相互作用，从而确定采购优先顺序和营运设计选择。

要了解市场，需要对多个细分维度进行细緻分析，这些维度决定了技术选择、营运规模和最终用户价值。依应用领域划分，市场可分为PET成像和放射性药物生产。 PET影像本身涵盖心臟病学、神经病学和肿瘤学等领域的应用，其中示踪剂特异性和成像频率会影响发生器的利用率。另一方面，放射性药物生产又分为商业生产和科学研究生产环境，两者各自有独特的产能和监管要求。

从区域来看，美洲、欧洲、中东和非洲以及亚太地区在实施模式、法规环境和采购行为方面存在明显差异。

区域趋势对整个发生器生态系统的技术采用模式、监管要求和投资重点都有显着影响。在美洲，成熟的临床PET部署和广泛的医院网路正在推动对自动化柱状系统和整合多通道配置的需求。同时，分销物流和区域製造能力影响集中式生产和分散式生产之间的选择。向数位化品质体系的转变以及对门诊影像中心日益增长的兴趣也在影响着采购决策和服务模式。

领先的发电机供应商如何透过结合自动化、服务生态系统、监管准备和供应链多元化来实现差异化并稳定收入来源？

发生器领域的竞争者正在探索创新、服务差异化和供应链优化之间的复杂互动，以期与临床和工业客户建立长期合作关係。主要参与者正在加速投资自动化、数位化品管和多通路架构，以满足多样化的需求，同时建立包括耗材供应、预防性保养和培训计画在内的服务生态系统，旨在减少停机时间并确保合规性。与放射性药物药房和契约製造建立策略合作伙伴关係正变得越来越普遍，这使得技术提供者能够参与到更广泛的价值链中，其范围不仅限于硬件，还包括长期试剂供应和商业规模生产。

供应商和机构买家应采取切实可行的策略重点，以加快采用速度、增强韧性，并使商业模式与临床需求保持一致。

产业领导者应推动一系列合作倡议，以巩固市场地位、提升韧性并加速采用发生器型PET示踪剂。首先，应优先开发和实施自动化整合系统，以减少对操作人员的依赖并确保可重复的品质。将硬体与数位品管和远距离诊断功能集成，将提高运转率并支援可扩展的生产模式。其次，应采用灵活的商业性安排，例如租赁、计量收费和捆绑式服务合同，以降低医院系统和诊断中心的准入门槛，同时确保收入和维护流程的可预测性。

我们严谨的混合研究途径，结合相关人员访谈、监管审查、技术文件分析和跨细分市场整合，揭示了可操作的行业洞察。

本分析的调查方法结合了定性和定量技术，旨在了解整个发生器生态系统中的技术趋势、相关人员的优先事项和营运考虑。主要工作包括与各类相关人员进行结构化访谈，这些利益相关者包括放射性药物管理人员、医院采购负责人、诊断中心运营人员、研究实验室管理人员、技术供应商和监管专家，以深入了解推动技术应用、维护实践和检验要求等方面的实用见解。此外，还进行了二次研究，查阅了监管指南、技术白皮书、关于PET在心臟病学、神经病学和肿瘤学领域应用的临床文献以及供应商技术文檔，以检验产品功能和市场定位。

观点是，技术进步、监管协调和供应链策略将是全面决定发生器辅助 PET 同位素获取未来的关键因素。

总之，镓-68发生器的供应处于临床应用机会与营运复杂性的交会点。技术创新，特别是自动化和整合系统设计的进步，显着提高了院内示踪剂生产的可靠性和扩充性，使其在心臟病学、神经病学和肿瘤学等领域得到广泛应用，同时也为研发和商业规模的放射性药物生产提供了支持。同时，供应链和政策的发展，包括关税趋势，正促使製造商和终端用户在采购、服务模式和资本规划方面进行策略调整。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：锗-68/镓-68发生器市场：依技术划分

  • 基于列
    • 自动化
    • 手动的
  • 整合系统
    • 多通道
    • 单通道

第九章：锗-68/镓-68发电机市场（依发电机容量划分）

  • 高容量
  • 小容量
  • 中等容量

第十章：锗-68/镓-68发生器市场：依应用领域划分

  • PET影像
    • 心臟病学
    • 神经病学
    • 肿瘤学
  • 放射性药物生产
    • 商业生产
    • 调查生产

第十一章：锗-68/镓-68发生器市场：依最终用户划分

  • 诊断中心
  • 医院
  • 製药公司
  • 研究机构

第十二章：锗-68/镓-68发生器市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：锗-68/镓-68发生器市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：锗-68/镓-68发生器市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国锗-68/镓-68发生器市场

第十六章：中国锗-68/镓-68发生器市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advanced Accelerator Applications
  • Anderson Publishing, Ltd.
  • BJ Madan & Co
  • BWX Technologies. Inc.
  • Cardinal Health.
  • Curium Pharma
  • Cyclotron Co. Ltd.
  • Eckert & Ziegler Radiopharma GmbH
  • Eckert & Ziegler Strahlen-und Medizintechnik AG
  • EDH Nuclear Medicine & Healtcare Services Ltd.
  • IBA Worldwide
  • Isotope JSC
  • Isotopia Molecular Imaging Ltd.
  • Kompass International SA
  • Lemer Pax
  • RadioMedix Inc.
  • Telix Pharmaceuticals Limited.
  • TEMA Sinergie
Product Code: MRR-546E6FBB361C

The Germanium-68 Gallium-68 Generators Market was valued at USD 44.50 billion in 2025 and is projected to grow to USD 51.06 billion in 2026, with a CAGR of 15.23%, reaching USD 120.09 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 44.50 billion
Estimated Year [2026] USD 51.06 billion
Forecast Year [2032] USD 120.09 billion
CAGR (%) 15.23%

A concise introduction to how Germanium-68/Gallium-68 generator technology is reshaping decentralized PET tracer supply and radiopharmaceutical workflows across care settings

The field of generator-produced positron-emitting isotopes remains central to molecular imaging and radiopharmaceutical production workflows. Germanium-68/Gallium-68 generator technology underpins decentralized supply chains for short-lived gallium-68, enabling hospitals, diagnostic centers, research institutes, and pharmaceutical companies to access PET tracers without reliance on immediate cyclotron access. As clinical demand for targeted PET diagnostics spreads across cardiology, neurology, and oncology, generator systems are adapting to meet heterogeneous user requirements while regulatory frameworks evolve to maintain patient safety and product quality.

Transitioning from historical, predominantly manual generator models, the industry now shows pronounced movement toward automated and integrated solutions that increase throughput, reproducibility, and compliance with current good manufacturing practices. This shift is occurring alongside intensified focus on supply chain resilience, where generator capacity segmentation from low to high capacity influences procurement strategies for commercial production versus research applications. Collectively, these dynamics are reshaping how end users evaluate technology choices, partner with suppliers, and structure their internal radiopharmacy operations to deliver consistent, high-quality PET imaging agents.

How technological innovation, clinical expansion beyond oncology, and supply chain resilience are driving major structural change in generator-based PET isotope ecosystems

The landscape for generator-sourced PET isotopes is undergoing transformative shifts driven by technological innovation, regulatory maturation, and evolving clinical paradigms. Automation and integrated system architectures are reducing operator variability and enabling multi-channel throughput, which in turn supports growing demand from both commercial production and high-volume hospital radiopharmacies. These technology advances are complemented by enhanced quality controls and digitally enabled traceability, which strengthen compliance with regional and international regulatory expectations.

Concurrently, clinical adoption of PET tracers beyond oncology-most notably in neurology and cardiology-has broadened the end-user base, prompting diagnostic centers and research institutes to reconsider on-site production capabilities. Supply chain strategies are also transforming: organizations are balancing the flexibility of local generator use against centralized manufacturing models, and many are investing in medium- to high-capacity generators that can serve multi-site networks. As these shifts unfold, strategic partnerships between technology providers, radiopharmacies, and clinical networks are emerging as a dominant theme, enabling faster translation of novel tracers into routine clinical pathways and more resilient access to isotopes for patient care.

An analytical review of how 2025 US tariff measures catalyzed sourcing realignment, cost management strategies, and procurement shifts across the generator supply chain

The tariff environment in the United States in 2025 introduced a new vector of operational and strategic pressure for suppliers and end users of generator systems and related consumables. Tariff measures applied to imported components and finished generator units altered cost structures for manufacturers that rely on globalized production chains, prompting reassessment of sourcing strategies and prompting some suppliers to explore nearshoring or domestic assembly to mitigate added import duties. These commercial reactions have important knock-on effects for procurement timelines, inventory policies, and capital expenditure decisions among hospitals, diagnostic centers, and commercial radiopharmacies.

As organizations adjusted to higher landed costs, purchasing behavior shifted toward longer-term service contracts, extended maintenance agreements, and a preference for integrated systems that could maximize uptime and throughput. Research institutes and smaller diagnostic centers faced particular strain when tariffs increased the price of replacement columns, shielding, and ancillary components, which accelerated consolidation of maintenance services and incentivized multi-year supply agreements. In response, some manufacturers restructured product portfolios to favor modular solutions that reduce customs exposure, while others intensified collaboration with regional distributors to smooth supply and offset tariff impacts through bundled service offerings. Overall, the tariff landscape of 2025 catalyzed a strategic reorientation across the value chain from sourcing to after-sales support, with resilience and total cost of ownership becoming decisive procurement criteria.

In-depth segmentation analysis revealing how applications, end users, technology types, and generator capacity jointly determine procurement priorities and operational design choices

Understanding the market requires a nuanced view across multiple segmentation axes that determine technology selection, operational scale, and end-user value. Based on application, the market divides between PET imaging and radiopharmaceutical production; PET imaging itself spans cardiology, neurology, and oncology use cases where tracer specificity and imaging cadence drive generator utilization, while radiopharmaceutical production separates into commercial production and research production environments, each with distinct throughput and regulatory demands.

From an end-user perspective, diagnostic centers, hospitals, pharmaceutical companies, and research institutes present diverse adoption drivers and constraints: diagnostic centers prioritize ease of use and routine tracer availability; hospitals emphasize integration with clinical workflows and compliance; pharmaceutical companies focus on scalable production and GMP alignment; research institutes value flexibility and experimental throughput. Technology segmentation distinguishes column-based and integrated systems; column-based options further differentiate between automated and manual approaches, influencing operator skill requirements and process consistency, while integrated systems are available as multi-channel or single-channel configurations to match throughput needs. Finally, generator capacity segmentation into high capacity, medium capacity, and low capacity defines which applications are feasible on-site and how sites balance capital expenditure against anticipated tracer demand. Together, these segmentation lenses illuminate paths for technology deployment, service models, and strategic partnerships across different organizational types and operational scales.

Regional examination of how the Americas, Europe Middle East & Africa, and Asia-Pacific exhibit distinct adoption patterns, regulatory contexts, and procurement behaviors

Regional dynamics exert a pronounced influence on technology adoption patterns, regulatory expectations, and investment priorities across the generator ecosystem. In the Americas, mature clinical PET adoption combined with extensive hospital networks has cultivated demand for both automated column-based systems and integrated multi-channel configurations, while distribution logistics and regional manufacturing capacity shape choices about centralized versus decentralized production. Transitioning to digital quality systems and increased interest in outpatient imaging centers also informs procurement decisions and service models.

The Europe, Middle East & Africa region presents a mosaic of regulatory regimes and infrastructure maturity, with pockets of highly advanced radiopharmacy capacity in Western Europe alongside emerging adoption in select Middle Eastern markets and evolving capabilities in parts of Africa. This diversity drives demand for scalable generator capacities and versatile technologies that can function reliably across disparate environments. In the Asia-Pacific region, rapid expansion of diagnostic services and growing investment in precision medicine are accelerating uptake of higher-capacity generators and integrated automated workflows, while regional manufacturing ecosystems and government-led healthcare initiatives influence localization strategies and partnership models. These regional differences underscore the importance of tailored commercial approaches, local regulatory navigation, and flexible service propositions for suppliers and institutional buyers alike.

How leading generator suppliers are combining automation, service ecosystems, regulatory readiness, and supply chain diversification to differentiate and stabilize revenue streams

Competitors in the generator space are navigating a complex interplay of innovation, service differentiation, and supply chain optimization to secure durable relationships with clinical and industrial customers. Leading players are accelerating investment in automation, digital quality management, and multi-channel architectures to address demand heterogeneity, while simultaneously developing service ecosystems that include consumable supply, preventive maintenance, and training programs to reduce downtime and ensure compliance. Strategic partnerships with radiopharmacies and contract manufacturers are increasingly common, enabling technology providers to participate in broader ecosystem value chains that extend beyond hardware into long-term reagent supply and commercial-scale production.

At the same time, companies are prioritizing regulatory readiness by investing in validation protocols, documentation frameworks, and traceability solutions that facilitate market entry across multiple jurisdictions. Competitive differentiation also arises from modular product offerings that allow customers to scale capacity as clinical or commercial needs evolve, and from financing or leasing models that lower upfront capital barriers for hospitals and diagnostic centers. In response to tariff pressures and supply chain volatility, manufacturers are diversifying sourcing, exploring regional assembly options, and enhancing distributor relationships to protect lead times. Collectively, these strategic moves reflect an industry balancing technological leadership with pragmatic commercial models that prioritize uptime, compliance, and predictable lifetime costs for end users.

Actionable strategic priorities for suppliers and institutional purchasers to accelerate adoption, strengthen resilience, and align commercial models with clinical demand

Industry leaders should pursue a coordinated set of actions to strengthen market position, enhance resilience, and accelerate adoption of generator-enabled PET tracers. First, prioritize development and deployment of automated and integrated systems that reduce operator dependency and ensure reproducible quality; coupling hardware with digital quality management and remote diagnostic capabilities will improve uptime and support scalable production models. Next, adopt flexible commercial arrangements, including leasing, pay-per-use, and bundled service contracts, to lower barriers for hospital systems and diagnostic centers while creating predictability in revenue and maintenance flows.

Additionally, invest in regional supply chain strategies that combine local assembly or final-stage manufacturing with robust distributor partnerships to mitigate tariff and logistics risks. Build regulatory readiness into product roadmaps by standardizing validation packages and harmonizing documentation to ease cross-border market entry. Strengthen collaborations with pharmaceutical companies and contract development and manufacturing organizations to support tracer commercialization pathways, and offer tailored solutions for research institutes that emphasize modularity and experimental flexibility. Finally, expand training and workforce development initiatives to ensure end users can safely and efficiently operate evolving technologies, thereby accelerating clinical adoption and fostering long-term customer loyalty.

A rigorous mixed-methods research approach combining stakeholder interviews, regulatory review, technical documentation analysis, and cross-segmentation synthesis to surface practical industry insights

The research methodology underpinning this analysis combined qualitative and quantitative techniques to capture technological trends, stakeholder priorities, and operational considerations across the generator ecosystem. Primary engagement included structured interviews with a range of stakeholders such as radiopharmacy managers, hospital procurement officers, diagnostic center operators, research laboratory leads, technology suppliers, and regulatory specialists to surface practical insights about adoption drivers, maintenance practices, and validation expectations. These conversations were complemented by secondary research that reviewed regulatory guidance, technology white papers, clinical literature on PET applications across cardiology, neurology, and oncology, and supplier technical documentation to verify product capabilities and positioning.

Analytical methods incorporated cross-segmentation synthesis, wherein application, end-user, technology, and capacity lenses were overlaid to identify consistent patterns and divergences in requirements. Scenario analysis explored the effects of supply chain disruptions and cost pressures-such as tariff changes-on procurement decisions and lifecycle costs, while vendor benchmarking assessed strategic approaches to automation, service delivery, and regulatory compliance. Where appropriate, findings were triangulated across sources to increase confidence in observed trends and to distinguish durable structural changes from transient market responses, ensuring the conclusions reflect current industry realities and practical implications for decision-makers.

Concluding perspective on how technological advances, regulatory alignment, and supply chain strategy collectively determine the future trajectory of generator-enabled PET isotope access

In sum, generator-based access to gallium-68 sits at the intersection of clinical opportunity and operational complexity. Technological innovation-particularly in automation and integrated system design-has materially improved the reliability and scalability of on-site tracer production, enabling broader clinical application across cardiology, neurology, and oncology as well as supporting both research and commercial-scale radiopharmaceutical production. Concurrently, supply chain and policy developments, including tariff dynamics, have prompted strategic realignment in sourcing, service models, and capital planning across manufacturers and end users.

Looking forward, suppliers that combine robust service ecosystems, modular product architectures, and regulatory-ready validation packages will be best positioned to capture durable customer relationships. End users that balance capacity planning with flexible procurement arrangements and invest in staff training will realize the greatest operational resilience and clinical throughput. Together, these factors indicate a market environment where technological capability, regulatory compliance, and pragmatic commercial design determine how effectively stakeholders convert generator access into reliable PET imaging and radiopharmaceutical outputs for patient care and research.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Germanium-68 Gallium-68 Generators Market, by Technology

  • 8.1. Column Based
    • 8.1.1. Automated
    • 8.1.2. Manual
  • 8.2. Integrated Systems
    • 8.2.1. Multi Channel
    • 8.2.2. Single Channel

9. Germanium-68 Gallium-68 Generators Market, by Generator Capacity

  • 9.1. High Capacity
  • 9.2. Low Capacity
  • 9.3. Medium Capacity

10. Germanium-68 Gallium-68 Generators Market, by Application

  • 10.1. Pet Imaging
    • 10.1.1. Cardiology
    • 10.1.2. Neurology
    • 10.1.3. Oncology
  • 10.2. Radiopharmaceutical Production
    • 10.2.1. Commercial Production
    • 10.2.2. Research Production

11. Germanium-68 Gallium-68 Generators Market, by End User

  • 11.1. Diagnostic Centers
  • 11.2. Hospitals
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Institutes

12. Germanium-68 Gallium-68 Generators Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Germanium-68 Gallium-68 Generators Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Germanium-68 Gallium-68 Generators Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Germanium-68 Gallium-68 Generators Market

16. China Germanium-68 Gallium-68 Generators Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advanced Accelerator Applications
  • 17.6. Anderson Publishing, Ltd.
  • 17.7. B. J. Madan & Co
  • 17.8. BWX Technologies. Inc.
  • 17.9. Cardinal Health.
  • 17.10. Curium Pharma
  • 17.11. Cyclotron Co. Ltd.
  • 17.12. Eckert & Ziegler Radiopharma GmbH
  • 17.13. Eckert & Ziegler Strahlen- und Medizintechnik AG
  • 17.14. EDH Nuclear Medicine & Healtcare Services Ltd.
  • 17.15. IBA Worldwide
  • 17.16. Isotope JSC
  • 17.17. Isotopia Molecular Imaging Ltd.
  • 17.18. Kompass International SA
  • 17.19. Lemer Pax
  • 17.20. RadioMedix Inc.
  • 17.21. Telix Pharmaceuticals Limited.
  • 17.22. TEMA Sinergie

LIST OF FIGURES

  • FIGURE 1. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MULTI CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MULTI CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MULTI CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY SINGLE CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY SINGLE CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY HIGH CAPACITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY HIGH CAPACITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY HIGH CAPACITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY LOW CAPACITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY LOW CAPACITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY LOW CAPACITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MEDIUM CAPACITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MEDIUM CAPACITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MEDIUM CAPACITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COMMERCIAL PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COMMERCIAL PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COMMERCIAL PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RESEARCH PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RESEARCH PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RESEARCH PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 156. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 157. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 158. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 160. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 161. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 183. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 184. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 185. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 187. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 188. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 192. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 193. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 194. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 196. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 197. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)